84-4031-69 Vasohibin-1 (FITC) 50ug 339382
特徴
- Angiogenesis inhibitor.
- Inhibits migration, proliferation and network formation by endothelial cells as well as angiogenesis.
- This inhibitory effect is selective to endothelial cells as it does not affect the migration of smooth muscle cells or fibroblasts.
- Does not affect the proliferation of cancer cells in vitro, but inhibits tumor growth and tumor angiogenesis.
- Acts in an autocrine manner.
- Inhibits artery neointimal formation and macrophage infiltration.
- Exhibits heparin-binding activity.
- Applications:Suitable for use in ELISA.
- Other applications not tested.
- Recommended Dilution:Optimal dilutions to be determined by the researcher.
- Storage and StabilityStore product at 4°C if to be used immediately within two weeks.
- For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20°C.
- Aliquots are stable at -20°C for 12 months after receipt.
- Dilute required amount only prior to immediate use.
- Further dilutions can be made in assay buffer.
- Caution: FITC conjugates are sensitive to light.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:50ug
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by Protein G affinity chromatography.
- Form:Supplied as a liquid in 0.01M PBS, pH 7.4, 0.03% Proclin 300, 50% glycerol. Labeled with Fluorescein isothiocyanate (FITC).
- Specificity:Human
- Isotype:IgG
- Calc Applications Abbrev:E
- Calc Crossreactivity:Hu
- Immunogen:Recombinant human Vasohibin-1 protein(1-204A)
- Shelf Life:1year
- Swiss Prot Number:Q7L8A9
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]